Noran Badeeb

Dr. Noran Badeeb


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Taiwan Journal of Ophthalmology
Verified
Journal Article
Open access
NBNoran Badeeb
Noran Badeeb
LRLina Raffa
Lina Raffa
HAHuda AhmedHussain
Huda AhmedHussain
DBDania Bamefleh
Dania Bamefleh
EMEnas Mgharbil
Enas Mgharbil
MAMohamed Albahiti
Mohamed Albahiti
PURPOSE: Retinopathy of prematurity (ROP) is a preventable blinding disorder affecting preterm infants. To date, maternal risk factors have not been studied in Saudi Arabia. This study aims to identify possible maternal risk factors for any stage and type 1 ROP. MATERIALS AND METHODS: A total of 295 preterm infants screened for ROP between November 2013 and December 2018 at a Saudi Arabian tertiary-care hospital were included. We included infants with a gestational age ≤ 32 weeks and/or birth weight (BW) ≤1500 g. We analyzed 28 maternal and neonatal risk factors. RESULTS: The incidence of ROP at any stage and Type 1 were 31.9% and 7%, respectively. In the univariate analysis, the only maternal factor associated with any stage of ROP was spontaneous vaginal delivery (P = 0.049), but no maternal factor was an independent risk factor for type 1 ROP. Multivariate logistic regression analysis identified lower BW, lower gestational age and longer neonatal intensive care unit stay as independent risk factors for the development of ROP at any stage (P < 0.05). For Type 1 ROP, lower BW, and intraventricular hemorrhage were significant independent risk factors (P < 0.05). CONCLUSION: The only maternal risk factor related to ROP was spontaneous vaginal delivery, which increased the risk of any stage of ROP. The single most predictive risk factor for any stage of ROP and Type 1 ROP was low BW. These findings emphasize the role of the obstetrician in promoting health care and modifying maternal risk factors to prevent preterm births related to a low BW.

28 December 2022 in Cureus
Verified
Journal Article
Open access
RARawan A Alsulami
Rawan A Alsulami
RAReema Alotaibi
Reema Alotaibi
GAGhadeer Alsulami
Ghadeer Alsulami
RARazan Alharbi
Razan Alharbi
RARaghad Alamoudi
Raghad Alamoudi
HKHanan Al Kadi
Hanan Al Kadi
Background: Wearing face masks has been an essential part of healthcare workers' lives since the coronavirus disease 2019 (COVID-19) pandemic. This study aims to determine the association between prolonged face mask-wearing and dry eye disorder (DED) among female nurses. Methods: An online questionnaire-based cross-sectional study was conducted at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, between May 2021 and February 2022. It covered sociodemographic data, conditions associated with ocular irritation, and questions related to mask-wearing duration. The Ocular Surface Disease Index (OSDI) survey was used to measure DED severity. Binary logistic regression analysis was done and Odd's ratios (OR) with 95% confidence intervals (CI) were reported. Results: A total of 266 female nurses responded to this study. The majority of the sample (71.1%) fell in the normal-mild DED category (OSDI 0-22), while (28.9%) were categorized as the moderate-severe DED category (OSDI >22). We found a significant independent association of dry eye disorder with wearing a mask for >6 hours/day (OR 2.066, 95% CI: 1.083-3.944). Other significant predictors of DED in this study were wearing corrective eyeglasses (OR 2.382, 95% CI: 1.296-4.376) and having rheumatoid arthritis (OR 17.289, 95% CI: 1.794-166.7). Conclusion: Wearing a face mask for > 6 hours/day was significantly associated with moderate to severe DED among female nursing staff. Ophthalmologists should be aware of this adverse effect in order to promote ways to relieve this condition.

30 April 2025 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
MHMohammed A. Halawani
Mohammed A. Halawani
NBNoran Badeeb
Noran Badeeb
Leber Hereditary Optic Neuropathy (LHON) and Autosomal Dominant Optic Atrophy (ADOA) are hereditary optic neuropathies characterized by mitochondrial dysfunctions causing destruction to the retinal ganglion cells and their axons, painless bilateral vision loss and symmetrical temporal pallor of the optic nerve. We present six intrafamilial cases with different manifestations of LHON and/or ADOA and their genetic variant profiles. Two brothers and their father had symptomatic bilateral vision loss, two sisters were asymptomatic, and the mother had left eye vision loss due to solar retinopathy; accompanied with headaches. Five of the patients had normal anterior and posterior segment exam aside from the affected optic nerves. The family pedigree showed an unaffected first generation and an affected male in the second generation. In the third generation, an affected male (the father in this family), diagnosed with optic atrophy due to OPA1 c.2383C > T variant, married a woman (the mother) carrying the LHON MT-ND4 m.11778G > A variant. Their offspring were one unaffected daughter, one affected daughter and two affected sons harboring both LHON and ADOA pathogenic variants inherited from their parents. Mitochondrial optic neuropathies, which result in loss of retinal ganglion cells, are a substantial cause of visual impairment. Herein, we report two cases of combined LHON- and ADOA-causing pathogenic variants in two brothers, in addition to the genetic and ophthalmologic profile of their parents and two sisters.

18 October 2022 in Journal of Neuro-Ophthalmology
Verified
Journal Article
Closed access
NBNoran Badeeb
Noran Badeeb
DLDaniel A. Lelli
Daniel A. Lelli
CTCarlos Torres
Carlos Torres
RKRustum Karanjia
Rustum Karanjia

13 February 2025 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
NBNoran Badeeb
Noran Badeeb
YAYara Alsolami
Yara Alsolami
MAMiad Alhamrani
Miad Alhamrani
FHFadi Hassanin
Fadi Hassanin
WAWaseem Aalam
Waseem Aalam
The retention of qualified faculty in medical colleges is hindered by low salaries and inadequate faculty-to-student ratios, despite intrinsic motivators like job satisfaction playing a critical role in faculty motivation. This study aims to understand and address the specific motivating factors and constraints within Saudi Arabia's medical education sector. A cross-sectional, validated online survey was conducted from November 2023 to January 2024 among physicians in Saudi Arabia's governmental and private sectors. Participants ranked teaching motivators and challenges using a Likert scale ranging from 5 (very important) to 1 (not very important). The collected data were analyzed using descriptive statistics and Chi-square test. Of the 145 respondents, 62.1% were male, with a mean age of 38.2 years (SD = 8.9). Saudi nationals comprised 54.5% of the sample. Sharing knowledge (64%) and educating the next generation (63%) were the top motivators. Notably, student preparedness was crucial for 45.5%. In contrast, extrinsic factors like financial gain (20%) and recognition events (9.7%) ranked lowest. The main challenges were heavy clinical workload (31.3%) and lack of time (28%). Preceptors were primarily motivated by intrinsic factors, with student preparedness being the most significant external factor. Time constraints and clinical workload were the major challenges to teaching. These insights can guide strategies to better support clinical educators.

19 August 2024 in Neuro-Ophthalmology
Verified
Journal Article
Closed access
NBNoran Badeeb
Noran Badeeb
SAShaima Alharazi
Shaima Alharazi
AMAsmaa Mohammedsaleh
Asmaa Mohammedsaleh
HHHasan Hijazi
Hasan Hijazi
NSNihal M. Sadaga
Nihal M. Sadaga
MHManal Hadrawi
Manal Hadrawi
Erythropoietin (EPO) has demonstrated neuroprotective properties and has been used in small case series to treat methanol optic neuropathy. This study aims to evaluate the effectiveness of EPO. This retrospective case series included data from patients diagnosed with methanol optic neuropathy between November 2022 and December 2023 from two centers in Jeddah, Saudi Arabia. Demographic information, time of consumption of methanol to EPO treatment, and other treatments administered were collected. Vision assessment was performed before and after EPO treatment. A total of 8 male patients were included, with an average age of 38.25 ± 7.15 years. The median duration of the follow-up was 66 days, ranging from 13 to 660 days. The means of vision in the logMAR of both eyes before EPO treatment was 1.98 ± 1.08, which changed to 1.87 ± 0.89 after EPO treatment. Patient's presenting vision before EPO treatment is a significant positive predictor for the vision after treatment with coefficient = 0.782 and 95% CI = 0.349, 0.936. Time to EPO treatment was not statistically significant in defining end vision. Treating methanol optic neuropathy is challenging and time sensitive. In this case series, EPO and adjuvant steroids showed variable effects on visual improvement. Although the vision improved after the treatment, these differences were not statistically significant. Repeat EPO did not give better outcomes. Long-term follow-up is needed to determine the overall impact of EPO treatment.